Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections

Vaccine

Volumn 34, Issue 34, 2016, Pages 4025-4031

  Shen, Chaoyun ^a   Ku, Zhiqiang ^a   Zhou, Yu ^a   Li, Dapeng ^a   Wang, Lili ^a   Lan, Ke ^a   Liu, Qingwei ^a   Huang, Zhong ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Coxsackievirus A6; Hand, foot, and mouth disease; Vaccine; Virus like particle

Indexed keywords

PROTEIN 3CD; PROTEIN P1; PROTEIN VP1; PROTEIN VP3; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; ANTISERUM; CAPSID PROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COXSACKIEVIRUS A6; ENTEROVIRUS; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; INSECT CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BACULOVIRIDAE; BAGG ALBINO MOUSE; BLOOD; COXSACKIEVIRUS INFECTIONS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; PASSIVE IMMUNIZATION; SF9 CELL LINE;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CAPSID PROTEINS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS; IMMUNE SERA; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; SF9 CELLS; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES;

EID: 84979283009     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.06.028     Document Type: Article

References (41)

1. [1] Repass, G.L., Palmer, W.C., Stancampiano, F.F., Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin J Med 81 (2014), 537–543.
2. [2] Wong, S.S., Yip, C.C., Lau, S.K., Yuen, K.Y., Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect 138 (2010), 1071–1089.
3. [3] Wu, Y., Yeo, A., Phoon, M.C., Tan, E.L., Poh, C.L., Quak, S.H., et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14 (2010), e1076–e1081.
4. [4] Xing, W., Liao, Q., Viboud, C., Zhang, J., Sun, J., Wu, J.T., et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis 14 (2014), 308–318.
5. [5] Bian, L., Wang, Y., Yao, X., Mao, Q., Xu, M., Liang, Z., Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide. Expert Rev Anti Infect Ther 13 (2015), 1061–1071.
6. [6] Lu, J., Zeng, H., Zheng, H., Yi, L., Guo, X., Liu, L., et al. Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic. Clin Microbiol Infect 20 (2014), O442–O445.
7. [7] Tan, X.J., Li, L., Zhang, B.M., Jorba, J., Su, X., Ji, T.J., et al. Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in 2013. Arch Virol 160 (2015), 1097–1104.
8. [8] Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 – Alabama, Connecticut, California, and Nevada, vol. 61, November 2011–February 2012. MMWR Morb Mortal Wkly Rep; 2012. p. 213–4.
9. [9] Mirand, A., Henquell, C., Archimbaud, C., Ughetto, S., Antona, D., Bailly, J.L., et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect 18 (2012), E110–E118.
10. [10] Blomqvist, S., Klemola, P., Kaijalainen, S., Paananen, A., Simonen, M.L., Vuorinen, T., et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol 48 (2010), 49–54.
11. [11] Guo, W.P., Lin, X.D., Chen, Y.P., Liu, Q., Wang, W., Wang, C.Q., et al. Fourteen types of co-circulating recombinant enterovirus were associated with hand, foot, and mouth disease in children from Wenzhou, China. J Clin Virol 70 (2015), 29–38.
12. [12] Gaunt, E., Harvala, H., Osterback, R., Sreenu, V.B., Thomson, E., Waris, M., et al. Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity. J Gen Virol 96 (2015), 1067–1079.
13. [13] Feng, X., Guan, W., Guo, Y., Yu, H., Zhang, X., Cheng, R., et al. A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012–2013. Sci Rep, 5, 2015, 11700.
14. [14] He, Y.Q., Chen, L., Xu, W.B., Yang, H., Wang, H.Z., Zong, W.P., et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol 51 (2013), 3560–3566.
15. [15] Zhang, C., Zhu, R., Yang, Y., Chi, Y.D., Yin, J.Y., Tang, X.Y., et al. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou city, Jiangsu province, China, in 2012–2013. Emerg Microb Inf, 2015, 4.
16. [16] Kaminska, K., Martinetti, G., Lucchini, R., Kaya, G., Mainetti, C., Coxsackievirus A6 and hand, foot and mouth disease: three case reports of familial child-to-immunocompetent adult transmission and a literature review. Case Rep Dermatol 5 (2013), 203–209.
17. [17] Sinclair, C., Gaunt, E., Simmonds, P., Broomfield, D., Nwafor, N., Wellington, L., et al. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill, 19, 2014, 20745.
18. [18] Lo, S.H., Huang, Y.C., Huang, C.G., Tsao, K.C., Li, W.C., Hsieh, Y.C., et al. Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect 44 (2011), 252–257.
19. [19] Wei, S.H., Huang, Y.P., Liu, M.C., Tsou, T.P., Lin, H.C., Lin, T.L., et al. An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis, 11, 2011, 346.
20. [20] Vuorinen, T., Osterback, R., Kuisma, J., Ylipalosaari, P., Epididymitis caused by coxsackievirus A6 in association with hand, foot, and mouth disease. J Clin Microbiol 52 (2014), 4412–4413.
21. [21] Richter, J., Koptides, D., Tryfonos, C., Christodoulou, C., Molecular typing of enteroviruses associated with viral meningitis in Cyprus, 2000–2002. J Med Microbiol 55 (2006), 1035–1041.
22. [22] Puenpa, J., Chieochansin, T., Linsuwanon, P., Korkong, S., Thongkomplew, S., Vichaiwattana, P., et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Thailand, 2012. Emerg Infect Dis 19 (2013), 641–643.
23. [23] Schmidt, N.J., Ho, H.H., Lennette, E.H., Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol 2 (1975), 183–185.
24. [24] Landry, M.L., Madore, H.P., Fong, C.K., Hsiung, G.D., Use of guinea pig embryo cell cultures for isolation and propagation of group A coxsackieviruses. J Clin Microbiol 13 (1981), 588–593.
25. [25] Yang, L., Li, S., Liu, Y., Hou, W., Lin, Q., Zhao, H., et al. Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice. Virus Res 210 (2015), 165–168.
26. [26] Ku, Z., Ye, X., Huang, X., Cai, Y., Liu, Q., Li, Y., et al. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS ONE, 8, 2013, e57601.
27. [27] Ku, Z., Ye, X., Shi, J., Wang, X., Liu, Q., Huang, Z., Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol 89 (2015), 12084–12095.
28. [28] Liu, Q.W., Ku, Z.Q., Cai, Y.C., Sun, B., Leng, Q.B., Huang, Z., Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods 173 (2011), 115–120.
29. [29] Liu, Q., Yan, K., Feng, Y., Huang, X., Ku, Z., Cai, Y., et al. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 30 (2012), 6642–6648.
30. [30] Ye, X., Ku, Z., Liu, Q., Wang, X., Shi, J., Zhang, Y., et al. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol 88 (2014), 72–81.
31. [31] Ku, Z., Liu, Q., Ye, X., Cai, Y., Wang, X., Shi, J., et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 32 (2014), 4296–4303.
32. [32] Chung, Y.C., Ho, M.S., Wu, J.C., Chen, W.J., Huang, J.H., Chou, S.T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26 (2008), 1855–1862.
33. [33] Chung, Y.C., Huang, J.H., Lai, C.W., Sheng, H.C., Shih, S.R., Ho, M.S., et al. Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12 (2006), 921–927.
34. [34] Gong, M.Q., Zhu, H.T., Zhou, J., Yang, C.T., Feng, J., Huang, X.J., et al. Cryo-electron microscopy study of insect cell-Expressed enterovirus 71 and coxsackievirus A16 virus-like particles provides a structural basis for vaccine development. J Virol 88 (2014), 6444–6452.
35. [35] Somasundaram, B., Chang, C., Fan, Y.Y., Lim, P.Y., Cardosa, J., Lua, L., Characterizing enterovirus 71 and coxsackievirus A16 virus-like particles production in insect cells. Methods 95 (2016), 38–45.
36. [36] Fujimoto, T., Iizuka, S., Enomoto, M., Abe, K., Yamashita, K., Hanaoka, N., et al. Hand, foot, and mouth disease caused by coxsackievirus A6, Japan, 2011. Emerg Infect Dis 18 (2012), 337–339.
37. [37] Liu, C.C., Chow, Y.H., Chong, P., Klein, M., Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine 32 (2014), 6177–6182.
38. [38] Klein, M., Chong, P., Is a multivalent hand, foot, and mouth disease vaccine feasible?. Hum Vacc Immunother 11 (2015), 2688–2704.
39. [39] Liu, Q., Tong, X., Huang, Z., Towards broadly protective polyvalent vaccines against hand, foot and mouth disease. Microbes Infect 17 (2015), 155–162.
40. [40] Cai, Y., Ku, Z., Liu, Q., Leng, Q., Huang, Z., A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine 32 (2014), 2406–2412.
41. [41] Sun, S., Jiang, L., Liang, Z., Mao, Q., Su, W., Zhang, H., et al. Evaluation of monovalent and bivalent vaccines against lethal enterovirus 71 and coxsackievirus A16 infection in newborn mice. Hum Vacc Immunother 10 (2014), 2885–2895.